The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
Author(s) -
Harish Seethapathy,
Sophia Zhao,
Donald F. Chute,
Leyre Zubiri,
Yaa Oppong,
Ian A. Strohbehn,
Frank B. Cortazar,
David E. Leaf,
Meghan J. Mooradian,
Alexandra–Chloé Villani,
Ryan J. Sullivan,
Kerry L. Reynolds,
Meghan E. Sise
Publication year - 2019
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.00990119
Subject(s) - medicine , creatinine , acute kidney injury , hazard ratio , renal function , incidence (geometry) , population , kidney disease , cumulative incidence , confidence interval , cohort , physics , environmental health , optics
Immune checkpoint inhibitor use in oncology is increasing rapidly. We sought to determine the frequency, severity, cause, and predictors of AKI in a real-world population receiving checkpoint inhibitors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom